Search

everythinglearnresearchcommunity

for

Search:↓

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for lupus show promise, but more research is needed, especially for children.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

New cytokine-targeted therapies show promise for treating alopecia areata.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.